Skip to content
healthcare.dev

Anagrelide

NDC 70954-879, Anagrelide, capsule, from ANI Pharmaceuticals, Inc..

Product NDC
70954-879
Status
Listed
Labeler
ANI Pharmaceuticals, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076811
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70954-879 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ANAGRELIDE HYDROCHLORIDE.5 mg/1

Pharmacologic classes

Decreased Platelet Production [PE]; Phosphodiesterase 3 Inhibitors [MoA]; Platelet-reducing Agent [EPC]

Package NDCNDC-11Package
70954-879-1070954087910100 CAPSULE in 1 BOTTLE (70954-879-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/56b3959d-4b6b-413f-b753-9d4c20c07466
  • NADAC price for package 70954087910

    GET /v1/drugs/nadac/70954087910

Use it

Look up 70954-879 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70954-879 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70954-879. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.